Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Busulfan-based reduced intensity conditioning regimens for haploidentical transplantation in relapsed/refractory Hodgkin lymphoma: Spanish multicenter experience.
Gayoso J, Balsalobre P, Pascual MJ, Castilla-Llorente C, López-Corral L, Kwon M, Serrano D, Piñana JL, Herrera P, Ferrá C, Pascual C, Heras I, Montesinos P, Zabalza A, Bento L, Figuera A, Buño I, Díez-Martín JL. Gayoso J, et al. Bone Marrow Transplant. 2016 Oct;51(10):1307-1312. doi: 10.1038/bmt.2016.115. Epub 2016 May 9. Bone Marrow Transplant. 2016. PMID: 27159177 Free article.
Impact of the kinetics of circulating anti-CD19 CAR-T cells and their populations on the outcome of DLBCL patients.
Martín-Martín L, Gutiérrez-Herrero S, Herrero-García M, Martín García-Sancho A, Yeguas A, Martín-López AÁ, López-Corral L, Pérez-López E, García-Blázquez M, Sánchez-Guijo F, Vidriales MB, Gaipa G; INCAR consortium; EuroFlow consortium; Orfao A. Martín-Martín L, et al. Blood Cancer J. 2024 May 17;14(1):83. doi: 10.1038/s41408-024-01065-z. Blood Cancer J. 2024. PMID: 38760376 Free PMC article. No abstract available.
Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic GVHD: A Report of Two Phase I/II Trials.
Rodríguez-Arbolí E, Lee CJ, Caballero-Velázquez T, Martínez C, García-Calderón C, Jiménez-León MR, Bermúdez-Rodríguez MA, López-Corral L, Triguero A, Onstad L, Horwitz ME, Sarantopoulos S, Lee SJ, Pérez-Simón JA. Rodríguez-Arbolí E, et al. Clin Cancer Res. 2023 Oct 13;29(20):4057-4067. doi: 10.1158/1078-0432.CCR-23-0666. Clin Cancer Res. 2023. PMID: 37698881
Helicobacter pylori infection and graft-versus-host disease.
Velasco Guardado A, López-Corral L, Pérez-Simón JA, Caballero-Velázquez T, Flores Corral T, Caballero Barrigón D, Rodríguez Pérez A. Velasco Guardado A, et al. Biol Blood Marrow Transplant. 2011 May;17(5):765-9. doi: 10.1016/j.bbmt.2010.11.014. Epub 2010 Nov 18. Biol Blood Marrow Transplant. 2011. PMID: 21093601 Free article.
Pretransplantation liver function impacts on the outcome of allogeneic hematopoietic stem cell transplantation: a study of 455 patients.
Barba P, Piñana JL, Fernández-Avilés F, Perez-Simón JA, Martino R, López-Guerrero E, Valcárcel D, Rovira M, Novelli S, Campos-Varela I, López-Anglada L, Vidal X, López Corral L, Carreras E, Sierra J. Barba P, et al. Biol Blood Marrow Transplant. 2011 Nov;17(11):1653-61. doi: 10.1016/j.bbmt.2011.04.009. Epub 2011 Apr 27. Biol Blood Marrow Transplant. 2011. PMID: 21586334 Free article.
Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Sureda A, Canals C, Arranz R, Caballero D, Ribera JM, Brune M, Passweg J, Martino R, Valcárcel D, Besalduch J, Duarte R, León A, Pascual MJ, García-Noblejas A, López Corral L, Xicoy B, Sierra J, Schmitz N. Sureda A, et al. Haematologica. 2012 Feb;97(2):310-7. doi: 10.3324/haematol.2011.045757. Epub 2011 Oct 11. Haematologica. 2012. PMID: 21993674 Free PMC article. Clinical Trial.
Incidence, characteristics and risk factors of marked hyperbilirubinemia after allogeneic hematopoietic cell transplantation with reduced-intensity conditioning.
Barba P, Martino R, Perez-Simón JA, Fernández-Avilés F, Piñana JL, Valcárcel D, Campos-Varela I, Lopez-Anglada L, Rovira M, Novelli S, Lopez-Corral L, Carreras E, Sierra J. Barba P, et al. Bone Marrow Transplant. 2012 Oct;47(10):1343-9. doi: 10.1038/bmt.2012.25. Epub 2012 Mar 5. Bone Marrow Transplant. 2012. PMID: 22388280 Clinical Trial.
Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients.
Labrador J, Lopez-Anglada L, Perez-Lopez E, Lozano FS, Lopez-Corral L, Sanchez-Guijo FM, Vazquez L, Perez Rivera JA, Martin-Herrero F, Sanchez-Barba M, Guerrero C, del Cañizo MC, Caballero MD, San Miguel JF, Alberca I, Gonzalez-Porras JR. Labrador J, et al. Haematologica. 2013 Mar;98(3):437-43. doi: 10.3324/haematol.2012.069559. Epub 2012 Aug 16. Haematologica. 2013. PMID: 22899581 Free PMC article.
The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate.
Perez-Simón JA, Martino R, Parody R, Cabrero M, Lopez-Corral L, Valcarcel D, Martinez C, Solano C, Vazquez L, Márquez-Malaver FJ, Sierra J, Caballero D. Perez-Simón JA, et al. Haematologica. 2013 Apr;98(4):526-32. doi: 10.3324/haematol.2012.065599. Epub 2012 Oct 12. Haematologica. 2013. PMID: 23065527 Free PMC article. Clinical Trial.
Impact of hyperferritinemia on the outcome of reduced-intensity conditioning allogeneic hematopoietic cell transplantation for lymphoid malignancies.
Barba P, Valcárcel D, Pérez-Simón JA, Fernández-Avilés F, Piñana JL, Martino R, López-Anglada L, Rovira M, Garcia-Cadenas I, Novelli S, Carreras E, López Corral L, Sierra J. Barba P, et al. Biol Blood Marrow Transplant. 2013 Apr;19(4):597-601. doi: 10.1016/j.bbmt.2012.12.018. Epub 2013 Jan 8. Biol Blood Marrow Transplant. 2013. PMID: 23305680 Free article.
122 results